Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |